“The usefulness of biotechnology firms’ drug development status in the evaluation of research and development costs”

Research output: Contribution to journalArticleProfessional

Original languageEnglish
Pages (from-to)197-205
JournalJournal of accounting, auditing & finance
Volume18
Issue number1
Publication statusPublished - 2003
Externally publishedYes

Cite this

@article{8afffeee4f7e4747a6286c1ce1936909,
title = "“The usefulness of biotechnology firms’ drug development status in the evaluation of research and development costs”",
author = "P.P.M. Joos",
year = "2003",
language = "English",
volume = "18",
pages = "197--205",
journal = "Journal of accounting, auditing & finance",
issn = "0148-558X",
publisher = "Greenwood Publishing Group Inc.",
number = "1",

}

TY - JOUR

T1 - “The usefulness of biotechnology firms’ drug development status in the evaluation of research and development costs”

AU - Joos, P.P.M.

PY - 2003

Y1 - 2003

M3 - Article

VL - 18

SP - 197

EP - 205

JO - Journal of accounting, auditing & finance

JF - Journal of accounting, auditing & finance

SN - 0148-558X

IS - 1

ER -